Chart of the Day: Bristol-Myers Squibb (BMY)

NYSE: BMY | Bristol-Myers Squibb Company  News, Ratings, and Charts

BMY – Bristol-Myers Squibb (BMY) is stuck in a sideways trading range. This could lead to a breakout or breakdown soon.

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Bristol-Myers Squibb (BMY) is trading sideways, within a range, and a rectangle pattern has formed that could lead to a breakout or breakdown sometime soon.

BMY discovers, develops, and markets drugs for various indications, such as cardiovascular, oncology, and immune disorders. The company’s immuno-oncology drug, Opdivo, and its blood thinner, Eliquis, drive growth for the company’s profits. The label expansion of Opdivo should continue to boost revenue.

Take a look at the 1-year chart of Bristol BMY below with added notations:

 Chart of BMY provided by TradingView 

After a very volatile spring, BMY has moved into a trading range and has formed a key resistance around $61 (red), and an important area of support around $57 (green).  At some point, the stock will have to break either above the $61 or below the $57 mark.

A trade could look to buy BMY when it exceeds $61, with the assumption of a breakout.  Or short BMY if it falls below $57, with the assumption of a breakdown.

Keep an eye out on August 6th for BMY’s latest earnings report. 

Have a great trading day!

Good luck!

Christian Tharp, CMT


Want More Great Investing Ideas?

5 WINNING Stock Charts  

9 “BUY THE DIP” Growth Stocks for 2020

Newly REVISED 2020 Stock Market Outlook

7 “Safe-Haven” Dividend Stocks for Turbulent Times

BMY shares were trading at $58.82 per share on Wednesday morning, down $0.61 (-1.03%). Year-to-date, BMY has declined -6.25%, versus a 1.47% rise in the benchmark S&P 500 index during the same period.

About the Author: Christian Tharp

Christian is an expert stock market coach at the Adam Mesh Trading Group who has mentored more than 4,000 traders and investors. He is a professional technical analyst that is a certified Chartered Market Technician (CMT), which is a designation awarded by the CMT Association. Christian is also the author of the daily online newsletter Todays Big Stock. More...

More Resources for the Stocks in this Article

TickerPOWR RatingIndustry RankRank in Industry
BMYGet RatingGet RatingGet Rating

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Top Stories on

: uber | Uber Technologies, Inc.  News, Ratings, and Charts

Betting On A Big Move In Uber

UBER or LYFT? Which Rideshare Service is Best For Traders?
NYSE: XOM | Exxon Mobil Corporation  News, Ratings, and Charts

Not All Stock Yields Are the Same

The lowest treasury bond in over 2 centuries has some stocks still in prime position like: XOM and PSA.
NYSE: AJG | Arthur J. Gallagher & Co.  News, Ratings, and Charts

3 Stocks that Wall Street Analysts Recommend to Buy

Analyst ratings can help investors make informed decisions on stocks. Here are four buy-rated stocks to consider: Arthur J. Gallagher & Co. (AJG), Brunswick Corp (BC), and Bandwidth (BAND).
NASDAQ: JD |, Inc. News, Ratings, and Charts

4 International E-Commerce Stocks You Need to Know About

The e-commerce market has been soaring as coronavirus fears have kept shoppers indoors. Here are four international e-commerce stocks riding the online shopping wave: (JD), MercadoLibre (MELI), Sea Limited (SE), and Jumia Technologies (JMIA).
NASDAQ: NFLX | Netflix, Inc. News, Ratings, and Charts

The Best FAANG Stock to Own This Month

Why I believe that of the five stocks that comprise the acronym FAANG, Netflix (NFLX) is the stock to own in August.

Read More Stories

More Bristol-Myers Squibb Company (BMY) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All BMY News